Gilead Sciences Inc. (GILD) Social Stream



Gilead Sciences Inc. (GILD): $74.89

0.12 (-0.16%)

POWR Rating

Component Grades

Momentum

F

Stability

B

Sentiment

Quality

B

Add GILD to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#4 of 359

in industry

GILEAD SCIENCES INC (GILD) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering GILD.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-14 17 $100 $63 $78.5 $77.31 1.54%
2021-11-19 18 $100 $63 $79.428 $77.31 2.74%
2021-12-07 18 $100 $63 $79.266 $77.31 2.53%
2021-12-14 19 $100 $63 $78.812 $77.31 1.94%
2021-12-22 19 $100 $63 $79.125 $77.31 2.35%
2022-01-07 18 $100 $63 $79.25 $77.31 2.51%
2022-01-10 17 $100 $72 $80.714 $77.31 4.4%
2022-01-25 17 $100 $72 $80.571 $77.31 4.22%
2022-02-01 18 $100 $72 $80.571 $77.31 4.22%
2022-02-02 18 $100 $71 $79.714 $77.31 3.11%
2022-02-03 18 $100 $69 $78.928 $77.31 2.09%
2022-02-18 18 $90 $69 $78.214 $77.31 1.17%
2022-03-07 18 $90 $65 $77.5 $77.31 0.25%
2022-03-16 17 $90 $65 $76 $77.31 -1.69%
2022-04-04 15 $90 $65 $75.5 $77.31 -2.34%
2022-04-12 15 $90 $63 $75.083 $77.31 -2.88%
2022-04-17 15 $90 $63 $74.75 $77.31 -3.31%
2022-04-29 15 $90 $63 $74.083 $77.31 -4.17%
2022-05-14 15 $90 $63 $74.166 $77.31 -4.07%
2022-05-16 15 $90 $63 $73.166 $77.31 -5.36%
2022-06-05 16 $90 $63 $72.769 $77.31 -5.87%
2022-08-03 17 $90 $65 $72.857 $77.31 -5.76%
2022-08-04 17 $90 $65 $72.923 $77.31 -5.67%
2022-08-14 17 $90 $65 $72.571 $77.31 -6.13%
2022-09-07 17 $90 $65 $72.785 $77.31 -5.85%
2022-09-17 17 $90 $65 $73.785 $77.31 -4.56%
2022-10-04 16 $90 $65 $74.357 $77.31 -3.82%
2022-10-21 16 $90 $60 $74.066 $77.31 -4.2%
2022-10-26 16 $90 $60 $74.2 $77.31 -4.02%
2022-10-28 16 $91 $60 $75.2 $77.31 -2.73%
2022-10-31 18 $96 $60 $77.733 $77.31 0.55%
2022-11-07 19 $96 $68 $81.733 $77.31 5.72%
2022-11-08 19 $96 $27 $78.937 $77.31 2.1%
2022-11-28 19 $96 $27 $79.562 $77.31 2.91%
2022-12-01 18 $105 $27 $81 $77.31 4.77%
2022-12-12 19 $105 $27 $81 $77.31 4.77%
2022-12-21 19 $105 $27 $81.5 $77.31 5.42%
2023-01-03 19 $105 $27 $83.812 $77.31 8.41%
2023-01-09 19 $105 $27 $84.312 $77.31 9.06%
2023-01-22 19 $111 $27 $84.75 $77.31 9.62%
2023-01-23 19 $111 $27 $85.687 $77.31 10.84%
2023-01-27 19 $111 $27 $86.125 $77.31 11.4%
2023-02-03 18 $111 $27 $86.125 $77.31 11.4%
2023-02-06 18 $115 $27 $87.5 $77.31 13.18%
2023-02-08 18 $115 $27 $87.058 $77.31 12.61%
2023-02-13 18 $115 $27 $87.352 $77.31 12.99%
2023-02-24 18 $115 $72 $91.705 $77.31 18.62%
2023-04-06 17 $115 $72 $90.375 $77.31 16.9%
2023-04-21 17 $115 $72 $90.625 $77.31 17.22%
2023-04-28 17 $115 $72 $90.687 $77.31 17.3%
2023-05-01 18 $115 $72 $90.75 $77.31 17.38%
2023-05-15 18 $115 $72 $91.647 $77.31 18.54%
2023-05-16 18 $115 $72 $91.647 $77.31 18.54%
2023-07-11 18 $115 $80 $93.294 $77.31 20.68%
2023-07-17 18 $115 $80 $93.117 $77.31 20.45%
2023-07-24 18 $115 $80 $92.529 $77.31 19.69%
2023-07-25 18 $115 $80 $92.235 $77.31 19.31%
2023-08-04 18 $115 $80 $92.176 $77.31 19.23%
2023-08-07 18 $115 $80 $91.47 $77.31 18.32%
2023-09-06 18 $115 $71 $90.333 $77.31 16.85%
2023-09-07 18 $115 $71 $90.333 $77.31 16.85%
2023-09-11 18 $115 $71 $90.722 $77.31 17.35%

The Trend in the Analyst Price Target


GILD's average price target has moved up $16.64 over the prior 17 months.

Over the past 52 weeks, GILD's average upside potential has been 8.16%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-10-21 17 90 60 73.800 67.79 8.87%
2023-01-03 19 105 27 83.812 85.39 -1.85%
2023-04-28 17 115 72 90.687 82.21 10.31%
2023-07-17 18 115 80 93.117 77.48 20.18%
2023-09-11 18 115 71 90.722 77.04 17.76%

GILD Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.89 10 0 8 0 0 18

The Trend in the Broker Recommendations


Over the past 28 months, GILD's average broker recommendation rating improved by 0.42.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • To contextualize these metrics, consider that out of all US stocks, GILEAD SCIENCES INC's number of analysts covering the stock is greater than 6320.41% of them.
  • GILEAD SCIENCES INC's upside potential (average analyst target price relative to current price) is greater than 879.34% of Pharmaceutical Products stocks.
  • GILD has a higher average analyst price target than 5890.33% of Pharmaceutical Products stocks.
  • GILD has a lower variance in analysts' estimates than -2252.13% of Pharmaceutical Products stocks.

Stocks similar to GILEAD SCIENCES INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are BIIB, TECH, and RGEN.

Is GILD a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!